The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 03, 2016
Filed:
Feb. 07, 2014
Applicant:
Loyola University Chicago, Maywood, IL (US);
Inventor:
Kenneth L. Byron, Chicago, IL (US);
Assignee:
Loyola University Chicago, Maywood, IL (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/38 (2006.01); A61K 31/155 (2006.01); A61K 31/167 (2006.01); A61K 31/27 (2006.01); A61K 31/415 (2006.01); A61K 31/555 (2006.01); G01N 33/50 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
A61K 31/167 (2013.01); A61K 31/27 (2013.01); A61K 31/415 (2013.01); A61K 31/555 (2013.01); G01N 33/5038 (2013.01); G01N 33/6872 (2013.01); G01N 2800/122 (2013.01); G01N 2800/32 (2013.01);
Abstract
Methods and combination pharmaceuticals for treating bronchospastic medical conditions by utilizing the electrophysiology of proteinacious channels in lipid membranes of mammalian cells. The combination pharmaceuticals include at least one β-adrenergic receptor agonist, and at least one composition adapted to effect the electrophysiology of Kv7 potassium channels of a lipid membrane of an airway smooth muscle cell. The pharmaceutical may be administered to a living body in a therapeutic amount sufficient to activate the Kv7 potassium channels of an airway smooth muscle cell.